Business Wire

ADVA

19.5.2020 09:02:13 CEST | Business Wire | Press release

Share
dacoso protects managed services with ADVA’s virtualized encryption technology

ADVA (FSE: ADV) today announced that dacoso is using its cloud-native security solution, ConnectGuard™ Cloud, to offer secure managed services. The virtualized encryption technology will give dacoso’s customers comprehensive data protection in cloud environments. With unprecedented scale and efficiency, dacoso will be able to roll out secure connectivity within minutes, safeguarding private, public, and edge/branch clouds at Layers 2, 3 and 4. Managed centrally in dacoso’s network by ADVA’s Ensemble Controller , the VPN services offer a major boost to the region’s businesses as they look to reduce costs and enhance flexibility by migrating more of their data and applications to the cloud. Now dacoso’s enterprise customers can harness the latest cloud tools while ensuring data integrity, regulatory compliance and true peace of mind for their end users.

“We’re excited to be offering our customers the comprehensive protection of ADVA’s ConnectGuard™ Cloud technology. For many of them, total cloud security is key to their business needs. By providing strong and flexible data protection in virtual environments, we’re enabling our customers to realize their full potential by accessing cloud applications with complete peace of mind,” said Karsten Geise, head of business and product development, dacoso. “We’re convinced by the robust security and performance benefits of ConnectGuard Cloud™. So much so that we’re already harnessing the solutions to protect our own branch and cloud locations. We understand its power to protect mission-critical data while also reducing costs and enhancing network utilization.”

Implemented entirely in software, ADVA’s ConnectGuard™ Cloud is a highly scalable, standards-compliant encryption solution that provides hybrid and multi-cloud environments with the ultimate defense against cyber threats. It enables dacoso to offer its customers high-performance, transport-layer-independent security with none of the performance issues of IPSec-based technologies. As a far more efficient and cost-effective alternative to hardware security appliances, ConnectGuard™ Cloud empowers dacoso’s customers to extend encryption to remote workers and branch offices by leveraging low-cost uCPE platforms. What’s more, with zero-touch provisioning, dacoso can roll out fully secured cloud connectivity almost instantly without any manual configuration.

“Our partnership with dacoso is great news for a huge number of enterprises across this region who are currently undergoing their digital transformation. With more and more of dacoso’s customers moving their workloads to cloud environments, our ConnectGuard™ Cloud technology provides the ideal way to ensure privacy and data integrity while keeping cost and complexity low,” commented Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “As a virtualized encryption solution with zero-touch provisioning and automated key management, our ConnectGuard™ Cloud is the most readily scalable option available. It improves operational simplicity and latency performance compared to appliance-based encryption methods. What’s more, it keeps latency at its lowest levels – a key requirement for many emerging cloud applications.”


About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

About dacoso
dacoso offers solutions for Connectivity, Virtual Networking and Cyber Security. The IT service provider thereby addresses companies that need their data to be highly available and secure yet without sacrificing agility. dacoso’s services comprise, among other, optical data links encrypted to satisfy BSI requirements (Federal Office for Information Security), a certified Security Operations Center, Managed Security Services and virtualization solutions to increase the dynamic performance of networks. dacoso GmbH is an owner-managed company headquartered in Langen near Frankfurt a.M. with a further 11 locations in Germany, Austria and Switzerland. www.dacoso.com

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

Social Media:

https://www.facebook.com/ADVAOpticalNetworking

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vonage and ServiceNow Expand their Partnership24.3.2026 09:20:00 CET | Press release

Vonage Contact Center with ServiceNow Voice integrates enterprise-grade voice and AI capabilities directly into enterprise workflows, boosting agent productivity and customer engagement Vonage, part of Ericsson (NASDAQ: ERIC), today announced the launch of its native integration with ServiceNow Voice, built on the ServiceNow AI Platform, embedding enterprise-grade voice and real-time AI capabilities directly into ServiceNow Customer Service Management (CSM) and IT Service Management (ITSM) workflows for Vonage Contact Center (VCC) customers. Vonage provides a unified service environment for enterprise customer service and IT support teams, enabling agents to deliver exceptional customer experiences while driving improvements to service performance. The integration of VCC with ServiceNow embeds real-time voice and AI capabilities into enterprise workflows, giving them the tools their agents need to streamline case progression, automate workflows, and reduce manual effort. Through the Vo

Omnes Partners With Apex Group to Tokenise Institutional Bitcoin Mining Structured Note on Base24.3.2026 09:00:00 CET | Press release

Omnes today announced a strategic partnership with Apex Group, a leading global financial services provider with over $3.5 trillion in assets serviced, to tokenise its flagship Omnes Mining Note "OMN". The OMN is an institutional grade structured note backed by Bitcoin hashrate, to be issued and managed on the Base Chain, the Ethereum L2 incubating at Coinbase, leveraging Apex Digital 3.0 for comprehensive tokenisation, administration, and transfer agency services as a fully integrated end to end solution. The OMN provides professional non-US investors with direct economic exposure to new Bitcoin production measured in hashrate, which is the computational power used to validate transactions and produce Bitcoin, without the operational complexities of managing mining infrastructure, hardware, energy, or regulatory hurdles. Issued as a secured debt note in Luxembourg, the tokenised OMN combines traditional financial structuring with blockchain enabled features, including on chain transfe

Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved24.3.2026 07:00:00 CET | Press release

Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of CHF 4.3m in 2024 to a loss of CHF 1.4m in 2025. Further key statements In September 2025, our development plan for corticorelin was validated at a meeting with the FDA, enabling Curatis to proceed toward a regulatory submission supporting a pivotal study in patients suffering from peritumoral brain edema (PTBE). In November 2025, Curatis raised CHF 1.2m to progress corticorelin. The cash position as of year end 2025 was comfortable, standing at CHF 1.9m. Recently, Curatis announced a license agreement for corticorelin for Japan with significant milestone payments. Business development and finances In 2025, product sales amounted to CHF 10.3m, while service revenue amounted to CHF 0.5m. On a full year basis, Curatis AG increased revenues in its distri

AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs24.3.2026 07:00:00 CET | Press release

From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of Nemluvio® (nemolizumab) in different patient populations with moderate-to-severe atopic dermatitis, including late-breaking data in pediatric patients, and share four posters on AKLIEF® (trifarotene)1-8 Additional presentations related to Dermatological Skincare will explore how artificial intelligence can identify high-risk factors for sensitive skin and Cetaphil® in different skin types9 Data from Galderma’s Injectable Aesthetics portfolio will also show how its hyaluronic acid injectables, Restylane®, and neuromodulator, RelabotulinumtoxinA*, may address aesthetic needs across the face and décolletage10-14 A total of 22 presentations will reinforce the value of Galderma’s broad and comprehensive portfolio in meeting varied patient needs across Therapeutic Dermatology, Injectable Aesthetics and Dermatological Skincare Galderma (SIX: GALD), the pure-play dermatology category leader, wi

Avanzanite Expands French Operations and Appoints Constance Sabbagh as General Manager24.3.2026 07:00:00 CET | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, France. Following a €32 million Series A investment by MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323639110/en/ Constance Sabbagh, General Manager, France “France is essential to Avanzanite’s European vision,” said Adam Plich, Co-founder and CEO of Avanzanite. “With its leadership in rare disease policy through its National Rare Disease Plans, care networks and scientific innovation, France is one of the most significant healthcare

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye